세계의 의료용 초고분자량 폴리에틸렌 모노머(UHMWPE) 시장 규모, 점유율 및 동향 분석 보고서 : 용도별, 지역별, 부문별 예측(2024-2030년)

Medical Grade Ultra High Molecular Weight Polyethylene Monomer Market Size, Share & Trends Analysis Report By Application (Knee Replacement, Hip Replacement), By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,194,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,571,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,325,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

의료용 초고분자량 폴리에틸렌 단량체 시장 성장 및 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면 세계 의료용 초고분자량 폴리에틸렌 단량체 시장 규모는 2024년부터 2030년까지 9.5%의 연평균 복합 성장률(CAGR)로 2030년까지 41억 6,000만 달러에 달할 것으로 예상됩니다.

높은 충격 강도, 낮은 반응성, 우수한 유연성 등 우수한 특성으로 인해 의료용 임플란트에서 이 소재의 효능이 예측 기간 동안 수요를 촉진할 것으로 예상됩니다.

UHMWPE는 긴 사슬을 가진 재료로 하중을 효율적으로 전달할 수 있어 임플란트 응용 분야에 적합합니다. 이 소재는 매우 유연하고 충격 강도가 높습니다. 또한 금속에 비해 무게가 가볍습니다. 이러한 모든 특성으로 인해 최근 몇 년동안 의료용 UHMWPE에 대한 수요가 증가하고 있으며, 이러한 추세는 예측 기간 동안 계속될 것으로 예상됩니다.

초고분자 폴리에틸렌은 관절 치환술에서 그 효과와 다양한 옵션으로 인해 초고분자량 폴리에틸렌이 사용되고 있습니다. 전 세계적으로 관절 치환술에 대한 수요가 급증하고 있습니다. 노인 인구 증가, 라이프스타일의 변화, 체력 부족이 이러한 추세의 원인으로 작용하고 있습니다. 이러한 추세는 향후 8년간 전체 수요에 긍정적인 영향을 미칠 것으로 예상됩니다.

주요 업계 참가자들은 더 긴 수명, 더 편안하고 강력한 기계적 성능을 갖춘 혁신적인 이식형 제품을 개발하기 위해 노력하고 있습니다. 시장 특징은 소수의 기업이 압도적인 매출 점유율을 차지하고 있다는 점입니다. 각 업체들은 증가하는 수요에 대응하기 위해 제품 포트폴리오와 생산 능력을 강화하기 위해 노력하고 있습니다.

의료용 초고분자량 폴리에틸렌 단량체 시장 보고서 하이라이트

• 무릎 인공관절 치환술은 골관절염 및 기타 관절 관련 질환의 유병률 증가로 인해 2023년 40.9%의 압도적인 점유율을 차지할 것으로 예상됩니다.
• 고관절 전치환술은 골관절염과 류마티스 관절염의 유병률 증가로 인해 예측 기간 동안 가장 빠른 CAGR을 나타낼 것으로 예상됩니다.
• 아시아태평양의 의료용 초고분자량 폴리에틸렌 모노머(UHMWPE) 시장은 2023년 40.5% 시장 점유율을 기록할 것으로 예상됩니다.
• 북미 의료용 초고분자량 폴리에틸렌 단량체 시장은 2023년 26.0% 시장 점유율을 확보했습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 의료용 초고분자량 폴리에틸렌 (UHMWPE) 모노머 시장 변수, 동향, 범위

• 시장 서론/계통 전망
• 시장 규모와 성장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 의료용 초고분자량 폴리에틸렌 (UHMWPE) 모노머 시장 분석 툴
  • Porter의 Five Forces 분석
  • PESTEL 분석

제4장 의료용 초고분자량 폴리에틸렌 (UHMWPE) 모노머 시장 : 용도 추정·동향 분석

• 부문 대시보드
• 의료용 초고분자량 폴리에틸렌 (UHMWPE) 모노머 시장 : 용도 변동 분석, 백만 달러, 수량 : 킬로톤, 2023년·2030년
• 인공 고관절 전치환술
• 슬관절 치환술
• 견관절 치환술
• 발목 치환술
• 소관절

제5장 의료용 초고분자량 폴리에틸렌 (UHMWPE) 모노머 시장 : 지역 추정·동향 분석

• 의료용 초고분자량 폴리에틸렌 (UHMWPE) 모노머 시장 점유율, 지역별, 2023년·2030년, 백만 달러, 수량 : 킬로톤
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 러시아
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 중국
  • 일본
  • 인도
  • 호주
  • 한국
  • 인도네시아
  • 베트남
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 사우디아라비아
  • 남아프리카공화국
  • 아랍에미리트(UAE)
  • 쿠웨이트

제6장 경쟁 구도

• 최근 동향과 영향 분석 : 주요 시장 진출기업별
• 기업 분류
• 기업 히트맵 분석
• 기업 개요
  • Celanese Corporation
  • DSM Biomedical
  • Honeywell International Inc.
  • Mitsui Chemicals, Inc.
  • TEIJIN LIMITED
  • LyondellBasell Industries Holdings B.V.
  • Orthoplastics Ltd.
  • Tianyi Biomedical Technology Co., Ltd.
  • Quadrant Engineering Plastic Products(Mitsubishi Chemical Advanced Materials)
  • Asahi Kasei Corporation

LSH

영문 목차

영문목차

Medical Grade Ultra High Molecular Weight Polyethylene Monomer Market Growth & Trends:

The global medical grade ultra high molecular weight polyethylene monomer market size is expected to reach USD 4.16 billion by 2030, registering a CAGR of 9.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. The effectiveness of the material in medical implants due to its superior properties such as high impact strength, low reactivity, and good flexibility is expected to drive the demand over the forecast period.

UHMWPE is a material having long chains which enable it to efficiently transfer load, thus making it suitable for implantation applications. The material is extremely pliable and has good impact strength. The material has less weight as compared to metals. All these properties have increased the demand for UHMWPE for medical applications in the recent past, and this trend is expected to continue over the forecast period.

Joint replacement surgeries use ultra high molecular weight polyethylene due to its effectiveness and versatility options. There has been a surge in demand for joint replacement surgeries across the globe. Rising geriatric population, changing lifestyle and lack of fitness are the contributing factors for this trend. This trend is expected to benefit the overall demand over next eight years.

Major industry participants are trying to develop innovative implantable products which have a longer life, are more comfortable, and give a strong mechanical performance. The market is characterized by few companies occupying a dominant revenue share. Companies are taking steps to increase the product portfolio and production capacity to meet the rising demand.

Medical Grade Ultra High Molecular Weight Polyethylene Monomer Market Report Highlights:

• Knee replacements have accounted for the dominant share of 40.9% in 2023 owing to the increasing prevalence of osteoarthritis and other joint-related conditions.
• Total hip replacement surgeries are expected to emerge at the fastest-growing CAGR during the forecast period owing to the escalating prevalence of osteoarthritis and rheumatoid arthritis.
• The medical grade ultra high molecular weight polyethylene monomers market in Asia Pacific registered 40.5% as the dominant market share in 2023.
• The North America medical grade ultra high molecular weight polyethylene monomers market secured 26.0% of the market share in 2023 owing to the region's growing investment in the healthcare infrastructure.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million) (Volume in Kilotons)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraints Analysis
• 3.4. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market: Application Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market: Application Movement Analysis, USD Million, Volume in Kilotons, 2023 & 2030
• 4.3. Total Hip Replacement
  • 4.3.1. Total Hip Replacement Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
• 4.4. Knee Replacement
  • 4.4.1. Knee Replacement Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
• 4.5. Shoulder Replacement
  • 4.5.1. Shoulder Replacement Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
• 4.6. Ankle Replacement
  • 4.6.1. Ankle Replacement Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
• 4.7. Small Joints
  • 4.7.1. Small Joints Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)

Chapter 5. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market: Regional Estimates & Trend Analysis

• 5.1. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer tMarket Share, By Region, 2023 & 2030, USD Million, Volume in Kilotons
• 5.2. North America
  • 5.2.1. North America Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.2.2. U.S.
    • 5.2.2.1. U.S. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.2.3. Canada
    • 5.2.3.1. Canada Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.2.4. Mexico
    • 5.2.4.1. Mexico Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
• 5.3. Europe
  • 5.3.1. Europe Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.3.2. U.K.
    • 5.3.2.1. U.K. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.3.3. Germany
    • 5.3.3.1. Germany Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.3.4. France
    • 5.3.4.1. France Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.3.5. Italy
    • 5.3.5.1. Italy Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.3.6. Spain
    • 5.3.6.1. Spain Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.3.7. Russia
    • 5.3.7.1. Russia Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.3.8. Demark
    • 5.3.8.1. Denmark Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.3.9. Sweden
    • 5.3.9.1. Sweden Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.3.10. Norway
    • 5.3.10.1. Norway Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
• 5.4. Asia Pacific
  • 5.4.1. Asia Pacific Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.4.2. China
    • 5.4.2.1. China Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.4.3. Japan
    • 5.4.3.1. Japan Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.4.4. India
    • 5.4.4.1. India Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.4.5. Australia
    • 5.4.5.1. Australia Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.4.6. South Korea
    • 5.4.6.1. South Korea Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.4.7. Indonesia
    • 5.4.7.1. Indonesia Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.4.8. Vietnam
    • 5.4.8.1. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
• 5.5. Latin America
  • 5.5.1. Latin America Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.5.2. Brazil
    • 5.5.2.1. Brazil Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.5.3. Argentina
    • 5.5.3.1. Argentina Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
• 5.6. Middle East and Africa
  • 5.6.1. Middle East and Africa Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.2. Saudi Arabia
    • 5.6.2.1. Saudi Arabia Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.6.3. South Africa
    • 5.6.3.1. South Africa Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.6.4. UAE
    • 5.6.4.1. UAE Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.6.5. Kuwait
    • 5.6.5.1. Kuwait Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis by Key Market Participants
• 6.2. Company Categorization
• 6.3. Company Heat Map Analysis
• 6.4. Company Profiles
  • 6.4.1. Celanese Corporation
    • 6.4.1.1. Participant's Overview
    • 6.4.1.2. Financial Performance
    • 6.4.1.3. Product Benchmarking
    • 6.4.1.4. Recent Developments/ Strategic Initiatives
  • 6.4.2. DSM Biomedical
    • 6.4.2.1. Participant's Overview
    • 6.4.2.2. Financial Performance
    • 6.4.2.3. Product Benchmarking
    • 6.4.2.4. Recent Developments/ Strategic Initiatives
  • 6.4.3. Honeywell International Inc.
    • 6.4.3.1. Participant's Overview
    • 6.4.3.2. Financial Performance
    • 6.4.3.3. Product Benchmarking
    • 6.4.3.4. Recent Developments/ Strategic Initiatives
  • 6.4.4. Mitsui Chemicals, Inc.
    • 6.4.4.1. Participant's Overview
    • 6.4.4.2. Financial Performance
    • 6.4.4.3. Product Benchmarking
    • 6.4.4.4. Recent Developments/ Strategic Initiatives
  • 6.4.5. TEIJIN LIMITED
    • 6.4.5.1. Participant's Overview
    • 6.4.5.2. Financial Performance
    • 6.4.5.3. Product Benchmarking
    • 6.4.5.4. Recent Developments/ Strategic Initiatives
  • 6.4.6. LyondellBasell Industries Holdings B.V.
    • 6.4.6.1. Participant's Overview
    • 6.4.6.2. Financial Performance
    • 6.4.6.3. Product Benchmarking
    • 6.4.6.4. Recent Developments/ Strategic Initiatives
  • 6.4.7. Orthoplastics Ltd.
    • 6.4.7.1. Participant's Overview
    • 6.4.7.2. Financial Performance
    • 6.4.7.3. Product Benchmarking
    • 6.4.7.4. Recent Developments/ Strategic Initiatives
  • 6.4.8. Tianyi Biomedical Technology Co., Ltd.
    • 6.4.8.1. Participant's Overview
    • 6.4.8.2. Financial Performance
    • 6.4.8.3. Product Benchmarking
    • 6.4.8.4. Recent Developments/ Strategic Initiatives
  • 6.4.9. Quadrant Engineering Plastic Products (Mitsubishi Chemical Advanced Materials)
    • 6.4.9.1. Participant's Overview
    • 6.4.9.2. Financial Performance
    • 6.4.9.3. Product Benchmarking
    • 6.4.9.4. Recent Developments/ Strategic Initiatives
  • 6.4.10. Asahi Kasei Corporation
    • 6.4.10.1. Participant's Overview
    • 6.4.10.2. Financial Performance
    • 6.4.10.3. Product Benchmarking
    • 6.4.10.4. Recent Developments/ Strategic Initiatives

관련자료